Cargando…

Polypharmacy and Excessive Polypharmacy Among Persons Living with Chronic Pain: A Cross-Sectional Study on the Prevalence and Associated Factors

PURPOSE: Polypharmacy can be defined as the concomitant use of ≥5 medications and excessive polypharmacy, as the use of ≥10 medications. Objectives were to (1) assess the prevalence of polypharmacy and excessive polypharmacy among persons living with chronic pain, and (2) identify sociodemographic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahlan, Ghita, De Clifford-Faugère, Gwenaelle, Nguena Nguefack, Hermine Lore, Guénette, Line, Pagé, M Gabrielle, Blais, Lucie, Lacasse, Anaïs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505027/ https://www.ncbi.nlm.nih.gov/pubmed/37719270 http://dx.doi.org/10.2147/JPR.S411451

Ejemplares similares

Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis
por: De Clifford-Faugère, Gwenaëlle, et al.
Publicado: (2023)

Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain
por: Godbout-Parent, Marimée, et al.
Publicado: (2022)

Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico‐administrative claims and patient‐reported data: The chronic pain treatment cohort
por: Lacasse, Anaïs, et al.
Publicado: (2021)

Gender Differences in Medication Adverse Effects Experienced by People Living With Chronic Pain
por: Nguena Nguefack, Hermine Lore, et al.
Publicado: (2022)

Pain Medications Used by Persons Living With Fibromyalgia: A Comparison Between the Profile of a Quebec Sample and Clinical Practice Guidelines
por: De Clifford-Faugère, Gwenaelle, et al.
Publicado: (2023)

Distinct care trajectories among persons living with arthritic conditions: A two-year state sequence analysis
por: Nguena Nguefack, Hermine Lore, et al.
Publicado: (2022)

Sex and gender differences in healthcare utilisation trajectories: a cohort study among Quebec workers living with chronic pain
por: Lacasse, Anaïs, et al.
Publicado: (2023)

Trajectory Modelling Techniques Useful to Epidemiological Research: A Comparative Narrative Review of Approaches
por: Nguena Nguefack, Hermine Lore, et al.
Publicado: (2020)

Conducting gender-based analysis of existing databases when self-reported gender data are unavailable: the GENDER Index in a working population
por: Lacasse, Anaïs, et al.
Publicado: (2020)

POLYPHARMACY IN ASSISTED LIVING
por: Galik, Elizabeth
Publicado: (2022)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Factors associated with excessive polypharmacy in older people
por: Walckiers, Denise, et al.
Publicado: (2015)

Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
por: Rieckert, Anja, et al.
Publicado: (2018)

Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy
por: Stuhec, Matej, et al.
Publicado: (2022)

Negotiating the polypharmacy paradox: a video-reflexive ethnography study of polypharmacy and its practices in primary care
por: Swinglehurst, Deborah, et al.
Publicado: (2023)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India
por: Nitya, S., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study
por: Lacasse, Anaïs, et al.
Publicado: (2021)

Polypharmacy: Misleading, but manageable
por: Bushardt, Reamer L, et al.
Publicado: (2008)

Polypharmacy among the Elderly
por: Hosseini, Seyed Reza, et al.
Publicado: (2018)

Polypharmacy in Zoological Medicine
por: Hunter, Robert P., et al.
Publicado: (2017)

Polypharmacy in the Homebound Population
por: Cook, Erin Atkinson, et al.
Publicado: (2022)

Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study
por: O'Dwyer, Máire, et al.
Publicado: (2016)

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
por: Sirois, Caroline, et al.
Publicado: (2019)

Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches
por: Nwadiugwu, Martin C.
Publicado: (2020)

Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status
por: Nwadiugwu, Martin C.
Publicado: (2021)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Effect of Pharmacist Intervention on a Population in Taiwan with High Healthcare Utilization and Excessive Polypharmacy
por: Wang, Tzu-Chueh, et al.
Publicado: (2019)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Polypharmacy In Psychiatry: A Review
por: Kukreja, Sanjay, et al.
Publicado: (2013)

Polypharmacy: The past, present and the future
por: Kaur, Ginpreet
Publicado: (2013)

Heart Failure Research and Polypharmacy
por: Somberg, John
Publicado: (2022)

An Atypical Case of Extreme Polypharmacy
por: Veronin, Michael A
Publicado: (2022)

White Esophagus: The Result of Polypharmacy
por: Andres, Brendan, et al.
Publicado: (2023)

Polypharmacy and relapse of schizophrenia: are they related?
por: Softic, R., et al.
Publicado: (2022)

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)
por: Mangin, Dee, et al.
Publicado: (2023)

Excessive polypharmacy and potentially inappropriate prescribing in 147 care homes: a cross-sectional study
por: MacRae, Clare, et al.
Publicado: (2021)

Prevalence and Predictors of Excessive Polypharmacy in Geriatric Inpatients: A Retrospective Cross-Sectional Study in Indonesia
por: Faisal, Shah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a8ke82ogtkdojbs04melmb8k0t